Foghorn Therapeutics Inc. (FHTX) Financials

FHTX Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 222.2 million 298.6 million
Dec. 31, 2025 198.1 million 306.6 million
Sept. 30, 2025 205.0 million 294.6 million
June 30, 2025 226.2 million 302.9 million

FHTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -25.3 million 2.4 million
Dec. 31, 2025 -22.3 million 2.2 million
Sept. 30, 2025 -18.9 million 2.7 million
June 30, 2025 -21.0 million 2.7 million

FHTX Net Income

No data available :(

FHTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 184.9 million - 40.1 million
Dec. 31, 2025 158.9 million - 40.3 million
Sept. 30, 2025 180.3 million - 22.5 million
June 30, 2025 198.7 million - 23.7 million

FHTX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 69.5 million
Dec. 31, 2025 63.0 million
Sept. 30, 2025 63.0 million
June 30, 2025 63.0 million

FHTX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 18.3 million 6.6 million -
Dec. 31, 2025 - 22.9 million 6.8 million -
Sept. 30, 2025 - 20.0 million 6.7 million -
June 30, 2025 22000 20.9 million 6.9 million -

FHTX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 3.3 million 238000
Dec. 31, 2025 9.2 million 802000
Sept. 30, 2025 8.2 million 20.0 million
June 30, 2025 7.6 million 900000

FHTX

Price: $4.01

52 week price:
3.27
6.95

Earnings Per Share: -1.17 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 18512

Market Capitalization: 219.0 million

Links: